Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice

Eur J Pharmacol. 2015 Jan 5:746:206-12. doi: 10.1016/j.ejphar.2014.11.017. Epub 2014 Nov 20.

Abstract

Postoperative cognitive dysfunction (POCD) is a frequent complication following major surgery in the elderly. However, the exact pathogenic mechanisms are still unknown. Dexmedetomidine, a selective alpha 2 adrenal receptor agonist, was revealed anesthesia and brain protective role. The present study aimed to examine whether dexmedetomdine protects against POCD induced by major surgical trauma under general anesthesia in aged mice. In the present study, cognitive function was assessed by Y-maze. Proinflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor (TNF-α), apoptosis-related factor caspase-3 and Bax were detected by real-time PCR, Western blot or immunohistochemistry. The results showed that anesthesia alone caused weak cognitive dysfunction on the first day after general anesthesia. Cognitive function in mice with splenectomy under general anesthesia was significantly exacerbated at the first and third days after surgery, and was significantly improved by dexmedetomidine administration. Splenectomy increased the expression of IL-1β, TNF-α, Bax and caspase-3 in hippocampus. These changes were significantly inversed by dexmedetomidine. These results suggest that hippocampal inflammatory response and neuronal apoptosis may contribute to POCD, and selective alpha 2 adrenal receptor excitation play a protective role.

Keywords: Aged; Anesthesia; Apoptosis; Dexmedetomidine; Inflammation; Postoperative cognitive dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists / administration & dosage
  • Adrenergic alpha-2 Receptor Agonists / adverse effects
  • Adrenergic alpha-2 Receptor Agonists / therapeutic use*
  • Aging*
  • Anesthetics, General / adverse effects
  • Animals
  • Apoptosis / drug effects
  • Apoptosis Regulatory Proteins / genetics
  • Apoptosis Regulatory Proteins / metabolism
  • Behavior, Animal / drug effects
  • Cognition Disorders / chemically induced
  • Cognition Disorders / metabolism
  • Cognition Disorders / pathology
  • Cognition Disorders / prevention & control*
  • Dexmedetomidine / administration & dosage
  • Dexmedetomidine / adverse effects
  • Dexmedetomidine / therapeutic use*
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects
  • Hippocampus / drug effects
  • Hippocampus / immunology
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Inflammation Mediators / metabolism
  • Maze Learning / drug effects
  • Mice, Inbred BALB C
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Neurons / drug effects
  • Neurons / immunology
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / adverse effects
  • Neuroprotective Agents / therapeutic use*
  • Neurotoxicity Syndromes / etiology
  • Neurotoxicity Syndromes / metabolism
  • Neurotoxicity Syndromes / pathology
  • Neurotoxicity Syndromes / prevention & control*
  • Postoperative Complications / chemically induced
  • Postoperative Complications / metabolism
  • Postoperative Complications / pathology
  • Postoperative Complications / prevention & control*
  • Random Allocation
  • Splenectomy / adverse effects

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Anesthetics, General
  • Apoptosis Regulatory Proteins
  • Inflammation Mediators
  • Nerve Tissue Proteins
  • Neuroprotective Agents
  • Dexmedetomidine